Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional
- PMID: 35230462
- DOI: 10.1007/s00134-022-06657-6
Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional
Comment in
-
Beyond failure or success: reflections on the ethical justifications for time-limited trial of intensive care.Intensive Care Med. 2022 Jul;48(7):969-970. doi: 10.1007/s00134-022-06752-8. Epub 2022 May 26. Intensive Care Med. 2022. PMID: 35618922 Free PMC article. No abstract available.
-
The moral problems with time-limited trials at the end-of-life, especially when clinicians and patients have different goals.Intensive Care Med. 2022 Sep;48(9):1262-1263. doi: 10.1007/s00134-022-06831-w. Epub 2022 Aug 1. Intensive Care Med. 2022. PMID: 35913639 No abstract available.
Comment on
-
Time-limited trial of intensive care is more than merely life sustaining.Intensive Care Med. 2022 Apr;48(4):507-508. doi: 10.1007/s00134-022-06644-x. Epub 2022 Feb 11. Intensive Care Med. 2022. PMID: 35146535 No abstract available.
References
-
- Cheung EH-L, Cheung JC-H, Yip Y-Y (2022) Time-limited trial of intensive care is more than merely life sustaining. Intensive Care Med. https://doi.org/10.1007/S00134-022-06644-X - DOI - PubMed - PMC
-
- Donaldson TM (2022) When the harms of intensive care treatment outweigh the benefits, the default use of time-limited trials is not ethically justifiable. Intensive Care Med 48(3):377–378. https://doi.org/10.1007/S00134-021-06607-8 - DOI - PubMed
-
- Donaldson TM (2021) Harming patients by provision of intensive care treatment: is it right to provide time-limited trials of intensive care to patients with a low chance of survival? Med Health Care Philos 24(2):227. https://doi.org/10.1007/S11019-020-09994-9 - DOI - PubMed - PMC
-
- Demyan L, Siskind S, Harmon L, Ramirez CL, Bank MA, Dela Cruz RA et al (2021) Do it to them, not to me: doctors’ and nurses’ personal preferences versus recommendations for end-of-life care. J Surg Res 264:76–80. https://doi.org/10.1016/J.JSS.2021.01.036 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
